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The molecular chaperone network plays a critical role in the formation and propagation of self-replicating yeast prions. Not only do individual prions differ in their requirements for certain chaperones, but structural variants of the same
prion can also display distinct dependences on the chaperone machinery, specifically Hsp104. The AAA+ ATPase Hsp104
is a disaggregase required for the maintenance of most known yeast prions. As a key component in the propagation of
prions, understanding how Hsp104 differs in its interaction with specific variants is crucial to understanding how prion
variants may be selected or evolve. Here, we investigate two novel mutations in Hsp104, hsp104-G254D, and hsp104G730D, which allow us to elucidate some mechanistic features of Hsp104 disaggregation and its requirement for activity
in propagating specific prion variants. Both Hsp104 mutants propagate the [PSI+] prion to some extent, but show a high
rate of prion loss. Both Hsp104-G254D and Hsp104-G730D display reduced biochemical activity, yet differ in their ability
to efficiently resolubilize disordered, heat-aggregated substrates. Additionally, both mutants impair weak [PSI+] propagation, but are capable of propagating the less stable strong [PSI+] variant to some extent. One of the Hsp104 mutants
also has the ability to propagate one variant of the [RNQ+] prion. Thus, our data suggest that changes in Hsp104 activity
limit substrate disaggregation in a manner that depends more on the stability of the substrate than the nature of the
aggregated species.

Introduction
Prions are self-templating, amyloidogenic protein aggregates.
In mammals, prions are associated with several neurodegenerative diseases, including scrapie in sheep, chronic wasting disease
in deer and elk, and Creutzfeldt-Jacob disease in humans.1,2 In
the budding yeast Saccharomyces cerevisiae, prions are non-toxic,
epigenetic elements of inheritance, but they do share many characteristics with mammalian prions and other disease-related
amyloidogenic proteins.3-5 The yeast prion [PSI+] results from a
self-propagating aggregated state of the translation termination
factor Sup35.6,7 Aggregation of Sup35 results in partial loss-offunction that leads to an increase in global nonsense suppression.8 Consequently, the ability to generate [PSI+] cells, coupled
with the reversible or metastable nature of this prion mechanism, has been proposed to be advantageous due to the ability
to alter phenotypes through the [PSI+]-dependent translation
of normally silent regions of the genome.9,10 Interestingly, the
appearance of the [PSI+] prion appears to be regulated by the
presence of another yeast prion, called [RNQ+] (or [PIN+])
which is the aggregated form of the Rnq1 protein.11-15 Though
the soluble protein Rnq1 (in [rnq−] cells) has no known function, the prion state of Rnq1, [RNQ+], functions to promote

the de novo induction of [PSI+], and is often required for the
aggregation of other amyloidogenic proteins in yeast.16
Although the prion conformation is self-templating, the
maintenance of prions in yeast relies on the molecular chaperone network to produce aggregates that can be transmitted from
mother to daughter cells. The AAA+ ATPase chaperone Hsp104
is a disaggregase required for the propagation of both [PSI+]
and [RNQ+], as well as all other recognized yeast prions.11,17-19
Hsp104, in concert with Hsp70 and Hsp40 chaperones, also
functions to resolubilize proteins that aggregate as a consequence of various environmental stresses.20,21 Hsp104 has five
distinct domains and is functional as a hexamer that contains a
central pore used for threading substrates.22-24 The N-terminal
domain is proposed to play a role in substrate recognition and
may also be a site for interaction of co-chaperones, though the
N-terminal domain is not required for either thermotolerance
or prion propagation.25 The two ATP-binding domains (NBD1
and NBD2), connected by a coiled-coil linker domain, both
bind and hydrolyze ATP to power the disaggregation mechanism.26,27 Lastly, the function of the fifth modular domain, the
C-terminal domain, is still mostly unclear, though some data
have implicated this domain as having a role in substrate interaction and processing.28,29
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The proposed role of Hsp104 in prion propagation is to fragment prion aggregates in order to generate the smaller heritable
species, or propagons.30-32 Consequently, deletion of Hsp104
eliminates both [PSI+] and [RNQ+], and several mutants in each
domain of Hsp104 have been characterized that affect [PSI+] and
[RNQ+] propagation.12,17,33-36 Interestingly, [PSI+] is especially
sensitive to changes in the Hsp104 system as the overexpression
of Hsp104 eliminates [PSI+] to generate [psi−] cells, whereas
Hsp104 overexpression does not eliminate [RNQ+].12,17,37,38
Hsp104 has also been shown to catalyze amyloid formation of
prion proteins in vitro.37,39,40 Furthermore, maintenance of prions
by Hsp104 is aided by Hsp70 and Hsp40 co-chaperones, and
overexpression or deletion of these chaperones can affect prion
propagation.41-47
Yeast prions exist as an array of self-propagating structures,
known as prion variants (analogous to “prion strains” in mammalian prion nomenclature). Although formed from the same
protein sequence, prion variants maintain distinct structures having varying stabilities and causing different cellular phenotypes,
much like mammalian prion strains result in variation in disease
pathology.48-52 Prion variants have been described for both [PSI+]
and [RNQ+]. [PSI+] variants are characterized by the amount of
nonsense suppression they confer, which is related to the ability of
the aggregate to template monomeric Sup35.53-55 Weak variants of
[PSI+] maintain an increased pool of monomeric Sup35 relative
to strong [PSI+] variants. As such, weak [PSI+] variants show less
nonsense suppression (more folded, soluble Sup35 means more
translation termination). Additionally, distinct Sup35 amyloid
structures have been generated using denatured, recombinant
protein (usually using just the prion-forming domain, also called
“NM”) by simply changing the temperature at which amyloid
fibers are formed.49,50 From structural studies of in vitro formed
amyloid, Sup35NM aggregates with a shorter protected amyloid core are less stable and give rise to a strong [PSI+] phenotype when [psi−] cells are infected with these aggregates, while
fibers with longer, more stable cores tend to give rise to weak
[PSI+] phenotypes upon infection.49,50,56 Recent data suggest that
the longer, more stable core associated with the weaker [PSI+]
variants is more refractory to Hsp104 activity or interaction.57,58
In contrast, the shorter core of strong variants is more labile
to Hsp104 disaggregation, resulting in the generation of more
propagons in strong [PSI+] cells, and thus increased conversion
of monomeric Sup35.57 As such, strong [PSI+] variants present a
stronger nonsense suppression phenotype as compared with weak
[PSI+] variants, and are better able to propagate when challenged
with fluctuations in Hsp104 activity.
Variants of [RNQ+] were first identified in vivo and were
characterized by their differential ability to facilitate formation
of the [PSI+] prion.15,59 These variants were named low, medium,
high, and very high [PIN+] to indicate their rate of [PSI+] induction.15 These [PIN+]/[RNQ+] variants were further described by
their patterns of fluorescence when Rnq1 was tagged with GFP.60
Two distinct phenotypes were observed: cells that contained multiple, small fluorescent foci termed multi-dot (m.d.), and cells
that contained a single, large fluorescent focus termed single-dot
(s.d.). [RNQ+] variants that induced [PSI+] at low, medium,
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high, and very high rates were all found within the microscopic
s.d. pattern, while only one m.d. [RNQ+] variant was characterized, and it induced [PSI+] at a high rate. Further investigation of
these established [RNQ+] variants showed that a distinct region
of the Rnq1 protein was required for propagation of certain variants, suggesting that [RNQ+] variants, like [PSI+], may also differ in their core region.61 Similar to Sup35, Rnq1 fibers display
distinct characteristics when generated under various conditions
in vitro,62 though structural studies to elucidate the amyloid core
of these [RNQ+] variants have not yet been done. Additionally,
much less is understood about the interaction between [RNQ+]
and Hsp104 and how changes in Hsp104 activity affect propagation of specific [RNQ+] variants.
Here, we characterize 2 novel mutations in Hsp104 that we
identified as causing a defect in [PSI+] propagation. We show
that these mutations decrease select activities of Hsp104, resulting in diminished disaggregation activity of specific substrates.
Finally, we find that defects in [PSI+] and [RNQ+] propagation
are specific for certain prion variants, thereby providing further
evidence for the hypothesis that Hsp104 may interact more efficiently with less stable [PSI+] variants than more stable variants,
and that this may also hold true for variants of [RNQ+].

Results
Point mutations in HSP104 cause a defect in the maintenance of [PSI+]
We performed a mutagenesis screen in order to identify factors
required for the propagation of a specific variant of the [PSI+]
prion. To identify such factors, we used a colony color based phenotypic assay commonly used to track [PSI+] prion propagation.
In this colorimetric assay, a premature stop codon in the ADE1
gene, ade1–14, blocks the completion of the adenine biosynthesis pathway and results in the accumulation of a red-pigmented
intermediate. Disruption of the pathway at this point also results
in the inability of these cells to grow on media lacking adenine.
Cellular changes that afford an increase in nonsense suppression
of the premature stop codon in ade1–14 can result in production
of sufficient Ade1 protein to generate light pink or white colonies
and allow for growth on media lacking adenine. Such an increase
in nonsense suppression can be generated by reduced function of
the translation termination complex (eRF1 and eRF3, or Sup45
and Sup35, respectively).8 This can occur either by mutation of
either termination factor or by conversion of wild type Sup35 into
a prion state. When Sup35 is monomeric and fully functional in
[psi-] cells, the premature stop codon in ade1–14 is recognized,
resulting in colonies that are red in color on rich media and cannot grow on media lacking adenine. When Sup35 is aggregated
in [PSI+] cells, however, the nonsense codon is suppressed and
the [PSI+] cells appear white on rich media and can grow on
media lacking adenine.
In addition, structural variants of the [PSI+] prion present a
range of color phenotypes indicative of the amount of soluble
Sup35 characteristic of those variants. For example, because of
the relative increase in soluble Sup35, weak [PSI+] strains harboring ade1–14 are pink in color on rich media. In our screen,
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we expected to find mutants that affected [PSI+] propagation
by a change in color phenotype from the light pink indicative
of strong [PSI+] in our parent 74-D964 strain. Interestingly, in
addition to mutations that completely inhibited [PSI+] propagation, we found a subset of mutations that partially inhibited
[PSI+] inheritance. These mutants displayed a sectoring color
phenotype on rich media (Fig. 1A). Color sectoring within a
[PSI+] colony results when a fraction of the budding daughter
cells lose the prion, thereby producing sections of the colony that
are [psi−] and phenotypically red. We identified 2 point mutations in the chaperone Hsp104 that demonstrated an interesting
effect on the inheritance of [PSI+] unlike the curing phenotype
that is often characterized. These mutants, which we sequenced
to identify as hsp104-G730D and hsp104-G254D, presented
varying levels of sectoring and [PSI+] loss (Fig. 1A). We recreated both mutants in an unmutagenized [PSI+] 74-D694 strain
by double homologous recombination to verify the phenotypic
effects and used these strains for all subsequent analyses.
In order to determine how the mutants affected the biochemical properties of Sup35 in [PSI+] cells, we first performed
SDD-AGE (semi-denaturing with detergent agarose gelelectrophoresis) 63 and analyzed the SDS-resistant Sup35 species.
In hsp104-G254D and hsp104-G730D cell lysates, we found that
the size of the Sup35 aggregate distribution was increased, as was
the amount of Sup35 monomer (Fig. 1B). From these data, one
could hypothesize that these Hsp104 mutants are unable to efficiently fragment Sup35 aggregates, resulting in larger aggregates
that cannot be as easily passed on to daughter cells. In addition,
less propagons would also result in decreased monomer addition
and a larger pool of monomeric Sup35. Alternatively, the mutants
could be propagating a weak variant of [PSI+] which would be
predicted to show the same change in aggregate pattern.
Strong [PSI+] propagons are maintained in both hsp104G254D and hsp104-G730D
The SDD-AGE analysis of the mutant strains (Fig. 1B)
showed an increase in both high-molecular weight species and
Sup35 monomer, which is characteristic of weak [PSI+] variants.30 However, the original [PSI+] variant in the screen was
strong [PSI+]. Thus, we used a genetic test and phenotypic
test to analyze whether the mutants appeared to be propagating a different variant of [PSI+] or if the variant propagated
in the sectoring colonies still appeared to be strong [PSI+]. As
the mutants are recessive, we could readily analyze the properties of the variant by mating the sectoring hsp104-G254D and
hsp104-G730D cells to wild type [psi−] cells, sporulating diploids, and analyzing resultant haploid progeny phenotypically and biochemically. Mating [PSI+] hsp104-G254D and
[PSI+] hsp104-G730D cells to wild type [psi−] cells resulted in diploids that were light pink, and more similar to the strong [PSI+] parent than the mutant haploids (Fig. 2A). Sporulation of the diploids
resulted in tetrads with 2 stable [PSI+] haploids and 2 sectoring/
weaker [PSI+] haploids. For both heterozygous diploids, the
2 haploid progeny that expressed wild type HSP104 resembled
strong [PSI+] phenotypically, by both color and growth on
media lacking adenine (Fig. 2B). Finally, we performed SDDAGE analysis on cell lysates from full tetrads obtained from the
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Figure 1. hsp104-G254D and hsp104-G730D strains show inefficient [PSI+]
propagation. (A) hsp104-G254D and hsp104-G730D cells display a sectoring [PSI+] phenotype as a result of inefficient [PSI+] inheritance. (B)
Lysates of sectoring hsp104-G254D and hsp104-G730D cells with strong
[PSI+] cells ([PSI+]) and [psi−] cells ([psi−]) as controls were analyzed by
SDD-AGE analysis followed by western blot and blotting for Sup35.
These results were reproduced at least three times. An example of the
shift is shown. The general loss of the lower aggregate species and the
decrease in aggregated Sup35 is reproducible. The appearance of monomeric Sup35 on SDD-AGE western blots is more variable, even with controls, for unknown reasons.

heterozygous diploids and compared the aggregate distribution
of the wild type HSP104 haploids to lysates from control cells
containing the parental strong [PSI+] variant. The biochemical
analyses correlated with the colorimetric phenotypes: all the wild
type haploids propagated Sup35 aggregates that resembled those
from control strong [PSI+] cell lysates (Fig. 2C). In sum, our
phenotypic and biochemical analyses suggest that the underlying
structure of Sup35 aggregates is retained in [PSI+] cells harboring the hsp104-G254D and hsp104-G730D mutations; however,
when these mutations are present as the only copy of Hsp104
in the cell they are unable to efficiently propagate the prion to
maintain the strong [PSI+] phenotype.
Hsp104 missense mutant proteins are defective in ATP
hydrolysis and efficient hexamer formation
As the increased size of the Sup35 aggregates in hsp104-G254D
and hsp104-G730D cells could suggest a fragmentation defect of
Hsp104, we next investigated whether these mutations affected
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of Hsp104 that display similarly low levels of
ATP hydrolysis often cure [PSI+].17,33
As ATP hydrolysis is dependent on the
ability of Hsp104 to form hexamers,64 we
next investigated whether these mutants
were capable of oligomerizing in the presence
of nucleotide.65 Using glycerol gradient fractionation in the presence of ATP, we found
that Hsp104-G254D and Hsp104-G730D
do form hexamers, though appear to do so
less efficiently than wild type, as there was
a slight shift in the peak of Hsp104-G254D
and Hsp104-G730D toward the top of the
gradient (Fig. 3). In the absence of ATP, wild
type Hsp104 and the mutant proteins do not
form hexamers (Fig. 3). Thus, the reduced
ATP hydrolysis of both Hsp104-G254D and
Hsp104-G730D may correlate with their
inefficient hexamerization ability.
We reasoned that if the majority of the
mutant were in the hexameric state, we
might observe wild type levels of ATPase
activity from the mutants. Hsp104 has previously been shown to hexamerize even in the
absence of ATP when incubated in a buffer
containing low salt (<20 mM).64 Therefore,
we again measured hydrolysis of ATP by
the Malachite green assay, this time in a low
salt (15 mM NaCl) buffer to promote hexamerization. In low salt buffer, we found
that the NBD2 mutant, Hsp104-G730D,
displayed ATPase activity similar to wild
type (Table 1). Hsp104-G254D, however,
did show an increase in ATP hydrolysis in
low salt buffer, but not to the same extent as
Figure 2. hsp104-G254D and hsp104-G730D cells propagate the original strong [PSI+] variant.
Hsp104 or Hsp104-G730D, suggesting the
(A) hsp104-G254D and hsp104-G730D cells (G254D and G730D, respectively) and diploids from
assembly defect of Hsp104-G254D may not
the mating of hsp104-G254D and hsp104-G730D to wild type [psi−] cells (WT/G254D and WT/
G730D) were spotted on rich media (YPD) and media lacking adenine (SD-Ade). Strong [PSI+]
be the only cause of the reduced rate of ATP
and [psi−] cells are spotted for comparison. The second spot in each row is a 5-fold dilution of the
hydrolysis.
first spot. (B) Full tetrads from the sporulation of the diploids in (A) were spotted for each mutant
Low activity mutations in HSP104 vary
as indicated. Each haploid progeny in the tetrad is labeled, A–D. Strong [PSI+] and [psi−] are
in their ability to disaggregate non-prion
spotted for color comparison. The second spot in each row is a 5-fold dilution of the first spot.
substrates
(C) Representative tetrads from (B) were analyzed by SDD-AGE analysis and western blot. The
letters A–D correspond to the haploids with the same label in (B) and weak [PSI+] (Weak), strong
In addition to its role in prion propaga[PSI+] (Strong) and [psi−] were analyzed for comparison. SDD-AGE analysis was performed four
tion, Hsp104 is also necessary for cell surtimes with haploids from both hsp104-G254D and hsp104-G730D cells.
vival following acute heat shock.21 With the
aid of Hsp70 and Hsp40 co-chaperones,
ATP hydrolysis. We purified recombinant wild type Hsp104, Hsp104 resolubilizes proteins that aggregate as a result of heat
Hsp104-G254D, and Hsp104-G730D proteins from E. coli or other stresses and is crucial for cellular recovery from such
cells. We then tested the ability of Hsp104-G254D and Hsp104- stresses.20 Therefore, we tested the ability of Hsp104-G254D
G730D to hydrolyze ATP by monitoring release of inorganic and Hsp104-G730D to promote thermotolerance. We first prephosphate using the Malachite Green assay.64 The G254 residue treated cells at 37 °C to induce Hsp104 expression, and then heatis in NBD1 and G730 is in NBD2 and as such, may be involved in shocked HSP104, hsp104Δ, hsp104-G254D, and hsp104-G730D
ATP binding or hydrolysis. As compared with wild type Hsp104, cells at 50 °C for various times as indicated, before plating on
both mutants (G730D and G254D) had significantly reduced rich media to determine the relative viability and recovery. We
ATPase activity (Table 1). Surprisingly, these results contradict found that both wild type HSP104 and hsp104-G254D were
previous results in the literature, which demonstrate that mutants thermotolerant, but hsp104-G730D cells were not, and resembled
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the hsp104Δ strain (Fig. 4). Thus, despite having lower ATPase
activity, Hsp104-G254D was more active in thermotolerance
assays than Hsp104-G730D, suggesting that the mechanism of
disaggregation is de-coupled from the ATP hydrolysis activity for
these 2 mutants.
hsp104-G254D and hsp104-G730D do not propagate weak
[PSI+]
Recently, it has been shown that some mutations in Hsp104
that reduce ATPase activity can impair the propagation of weak
[PSI+] variants, but not strong [PSI+] variants.66 Accordingly,
we next tested the ability of hsp104-G254D and hsp104-G730D
to propagate weak [PSI+] variants. We mated hsp104-G254D
[psi−] and hsp104-G730D [psi−] cells to 2 previously characterized weak [PSI+] variants and examined the diploids
and haploid progeny phenotypically and biochemically.49,53
In both weak [PSI+] variants, the heterozygous diploids displayed decreased nonsense suppression as compared with the
wild type weak [PSI+] parent (Fig. 5A). These data suggest
that both hsp104-G254D and hsp104-G730D were inhibiting
weak [PSI+] propagation, even in the presence of wild type
HSP104. Heterozygous diploids expressing wild type HSP104
and hsp104Δ maintained weak [PSI+], suggesting that the
decreased nonsense suppression observed in the mutant diploids is not just the result of reduced Hsp104 expression (data
not shown). Resultant tetrads were either all red and [psi−],
or segregated 2:2 weak [PSI+]:[psi−] (Fig. 5B and data not
shown) where the [PSI+] progeny segregated with the wild type
HSP104. Presumably, the reduced activity of Hsp104-G254D
and Hsp104-G730D prevent weak [PSI+] propagation and also
partially inhibit wild type Hsp104 from stably propagating
weak variants. Next, we chose tetrads that maintained weak
[PSI+] in the wild type haploids for SDD-AGE analysis and
found that the variant propagated resembled the weak [PSI+]
parent (Fig. 5C). Thus, hsp104-G254D and hsp104-G730D
do not irreversibly decrease the ability of wild type HSP104 to
propagate weak [PSI+] variants and do not appear to alter the
prion variant structure by phenotypic assays.
hsp104-G730D propagates a known variant of [RNQ+]
Like [PSI+], the [RNQ+] prion is also dependent on Hsp104
for its maintenance.12 To determine if the prion propagation
defect observed in hsp104-G254D and hsp104-G730D cells
was specific to [PSI+], we tested the ability of both mutants to
propagate several established [RNQ+] variants. After mating
[psi−] hsp104-G254D and [psi−] hsp104-G730D cells to the
s.d. low, medium, high, very high, and m.d. high variants of
[RNQ+]59 and sporulating the diploids, we performed SDDAGE on the hsp104-G254D and hsp104-G730D haploids to
determine the [RNQ+] state of the cells. Interestingly, we found
one variant of [RNQ+], the m.d. high variant, that was propagated, at least to some extent, in hsp104-G730D cells (Fig. 6).
None of the s.d. variants could be propagated by hsp104-G730D,
and hsp104-G254D did not propagate any of the [RNQ+] variants tested (data not shown). Thus, similar to recent reports for
[PSI+], these data may suggest that the m.d. [RNQ+] variant is
less stable than the s.d. [RNQ+] variants and thus more refractory to changes in the activity or interaction with Hsp104.
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Figure 3. Hsp104-G254D and Hsp104-G730D mutant proteins form
hexamers in vitro. Hsp104 (blue), Hsp104-G254D (green), and Hsp104G730D (red) were incubated with (solid color) or without (hatched) 5 mM
ATP for 10 min then subjected to ultracentrifugation through a linear
(10–35%) glycerol gradient. Equal volume fractions were collected
and the amount of Hsp104 protein in each fraction was analyzed by
SDS-PAGE and western blot. Individual bands were quantified and the
amount of Hsp104 in each fraction was plotted as a percent of the total
Hsp104 protein. The graph shows the data from one assay. This assay was
performed three times and all gave similar results.

Table 1. Hsp104 mutants display defects in ATP hydrolysis under physiological salt conditions
Physiological*

Low†

WT

0.225 ± 0.0397

0.732 ± 0.0543

G254D

0.0325 ± 0.00177

0.211 ± 0.00177

G730D

0.00583 ± 0.00439

0.677 ± 0.0321

Numbers represent the average initial rate (nmol µg-1 min-1) of ATP hydrolysis for WT Hsp104, Hsp104-G254D, and Hsp104-G730D. ATPase assays were
measured by the Malachite Green assay. Rates were calculated from 3 separate experiments from 2 different preparations of purified protein. *Buffer
contains 150 mM NaCl. †Buffer contains only 15 mM NaCl.

Discussion
Here, we identify 2 novel mutations in Hsp104, Hsp104G254D, and Hsp104-G730D, which affect Hsp104 activity
in a substrate- and prion variant-specific manner. Cells carrying the NBD1 mutant, hsp104-G254D, or the NBD2 mutant,
hsp104-G730D, display high mitotic loss of the strong variant of
[PSI+]. Phenotypically, hsp104-G730D displays a high degree of
sectoring while hsp104-G254D exhibits fewer sectoring colonies
but more completely red [psi−] colonies. Both mutants showed
marked reductions in ATP hydrolysis activity under physiological conditions, though a second copy of either mutant did not
alter the sectoring [PSI+] phenotype (data not shown). Despite
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Figure 4. hsp104-G254D and hsp104-G730D display different levels of non-prion disaggregation. The thermotolerance of HSP104, hsp104Δ, hsp104G254D, and hsp104-G730D cells was tested. Cells were first grown at 37 °C in liquid culture to induce HSP104 expression, heat-shocked at 50 °C for 10 to 30
min as indicated, and then spotted on rich media. Control cells (no heat) were plated without heat shock. Thermotolerance assays were repeated four
times and all showed similar results.

similar biochemical activities, the mutants differed in their ability to disaggregate a broad range of substrates, though both
are unable to propagate weak variants of [PSI+]. The hsp104G254D mutant is active in thermotolerance, but is defective in
the propagation of all tested variants of [RNQ+]. On the other
hand, Hsp104-G730D expressing strains are unable to resolve
disordered aggregates but, curiously, can propagate at least one
variant of the [RNQ+] prion to some extent.
Manipulation of the chaperone network has long been known
to regulate prion propagation and formation.17,20,27,67 Hsp104 is a
general prion regulator;26,68,69 deletion of Hsp104 eliminates all
of the known yeast prions and dependence on Hsp104 is often
one of the criteria used when identifying new yeast prions.18,70-72
Therefore, we were not surprised when several candidates from
our mutagenesis screen for factors involved in [PSI+] propagation were identified as mutations in Hsp104. Several interdependent features of Hsp104 contribute to its overall function
in substrate disaggregation, and understanding the effect these
features have on each other is not simple. For example, as an
AAA+ ATPase, hydrolysis of ATP provides the primary energy
for the disaggregase ability of Hsp104 and yet we identified two
mutations, Hsp104-G254D in NBD1 and Hsp104-G730D in
NBD2, that still disaggregate substrates despite having significantly lower rates of ATP hydrolysis. Interestingly, reducing the
ATPase activity of Hsp104 was previously shown to enhance
substrate disaggregation.73,74 However, the increased disaggregation ability extended only to disordered substrates; decreased
ATPase activity instead impaired prion remodeling.66,73 On
the other hand, a highly characterized mutation in the Walker
B motif in NBD1, E285A/Q, hydrolyzes ATP at a rate much
higher than wild type (300–500%), but fails to support either
thermotolerance or prion propagation.74 Therefore, ATP hydrolysis is not always a reliable indicator for substrate disaggregation
ability.
One hypothesis proposed suggested that disordered substrates
are less stable and thus require less overall force by Hsp104 to be
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disaggregated.66 High temperature and other stresses result in
the increased exposure of hydrophobic regions in proteins, leading to the formation of unstable, heterogeneous protein aggregates. Unlike these stress-induced aggregates, prions are highly
ordered, stable protein aggregates that are typically resistant to
denaturation by detergents and high temperatures. Mutations
in Hsp104 that promote thermotolerance but are not sufficient for prion propagation have been previously described.33
Interestingly, hsp104-G730D cells can propagate strong [PSI+]
and m.d. high [RNQ+], but are unable to function in thermotolerance. Additionally, mutations in the C-terminal domain
including K774E, L814S, L840Q, and 22 or 38 residue deletions of the C-terminus cause a loss of thermotolerance but these
mutants are able to propagate [PSI+] to some extent.29,75 These
previously characterized mutants are similar to Hsp104-G730D
in that they exhibit reduced ATP hydrolysis and show defects in
hexamerization.29 As yet, no function has been ascribed to the
Hsp104 C-terminal domain, though some data suggest it is a site
of substrate interaction.28
The hypothesis that Hsp104 is better able to remodel less
stable aggregates can also be applied to the broad range of
prion variants.57 Despite having the same sequence, prion variants are comprised of distinct structures that vary in stability
and hence, may vary in their interaction with Hsp104. Hsp104
has previously been shown to play a role in prion variant selection.76 Continued expression of high levels of Hsp104 resulted
in propagation of a [PSI+] variant dependent on overexpression of Hsp104.77 Additionally, recent data show that, like with
disordered aggregates, less stable variants of [PSI+] are more
efficiently remodeled by Hsp104 despite equal binding affinities for Hsp104.57 At low concentrations, Hsp104 catalyzed the
generation of prion-competent seeds of strong variants but was
unable to remodel weak variants. Therefore, the decreased activity of our Hsp104 mutants may specifically inhibit weak variants of [PSI+] in vivo due to the inability to interact with or
remodel this specific amyloid structure or any structure that is
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more stable. Moreover, expressing
the mutant concurrently with
wild type, as seen in the diploids,
caused mitotic loss of weak [PSI+]
variants, thereby supporting previous results indicating that weak
variants require a high level of
cooperativity between hexameric
subunits to propagate.66
In addition to causing unstable
strong [PSI+] propagation, hsp104G730D is also able to propagate
m.d. high [RNQ+] to some extent.
The m.d. high [RNQ+] variant
has been shown to be less thermal-stable than the s.d. [RNQ+]
variants.61,77 We have previously
published another mutation in
Hsp104, E190K, which also had a
differential effect on the propagation of the [RNQ+] variants. Like
hsp104-G730D,
hsp104-E190K
was unable to maintain the s.d.
variants, but was able to propagate
m.d. high [RNQ+].34 Additionally,
Figure 5. Neither hsp104-G254D nor hsp104-G730D can propagate weak [PSI+]. (A) [psi-] hsp104-G254D and
both hsp104-G730D and hsp104[psi-] hsp104-G730D cells were mated to either weak [PSI+] or the weak [PSI+] variant Sc37. Heterozygous
E190K showed defects in both
HSP104 and hsp104 mutant diploids (Weak/mut and Sc37/mut) from these matings and haploid parents
(Cured, Weak, Sc37) were spotted on YPD to assess phenotype. The second spot in each row is a 5-fold dilu[PSI+] propagation and thermotion
of the first spot. (B) Diploids of the mutants crossed to weak [PSI+] (Weak/Mut in A) were sporulated
tolerance. Our data from these two
and 16 tetrads dissected. Two representative tetrads on YPD are shown. Each haploid is labeled A–D. (C)
mutants suggest that variants of the
Diploids of weak [PSI+] crossed to the mutants (Weak/Mut in A) and a representative tetrad from these het[RNQ+] prion may be regulated by
erozygous diploids were subjected to SDD-AGE and western blot analysis to determine Sup35 aggregate
Hsp104 in a manner similar to the
distribution. SDD-AGE analysis was performed twice using four distinct tetrads.
mechanisms elucidated for [PSI+].
Interestingly, the m.d. [RNQ+]
variant that is the most resistant to alterations in Hsp104 activ- prions. Understanding how changes in the chaperone network
ity also facilitates a high rate of [PSI+] induction. It’s interesting regulate prion variant formation and propagation will broaden
to theorize that changing environmental conditions may cause our understanding of the mechanisms of prion variant generafluctuations in Hsp104 activity that in turn control the appear- tion, selection, and evolution.
ance and disappearance of prions, and as such, the environment
Materials and Methods
may influence prion-dependent phenotypic variation, adaptability and survival in different conditions. Therefore, discerning
Hsp104’s mechanism of disaggregation, as it applies to distinct
Strain and plasmid construction
prion variants, is critical to understanding how prions appear,
S. cerevisiae strains used in this study were derivatives of
disappear, and evolve.
74-D694 and were grown and manipulated using standard techAs our understanding of self-propagating prions continues niques. Yeast strains were either grown in rich media (1% yeast
to develop, so too does the knowledge that the biological phe- extract, 2% peptone, 2% glucose) or synthetic media lacking
nomenon of protein-only heritability is highly complex. In addi- amino acids corresponding to plasmid selection (0.67% yeast
tion to mutations in the primary sequence affecting aggregation nitrogen base, 2% glucose) or nonsense suppression analyses.
and propagation, we now understand that the same primary Diploids were generated by mating haploids containing selectsequence can adopt multiple conformations, and these con- able plasmids and were verified by growth on minimal media
formations differ in stability, heritability, and function. How and plating on haploid tester strains. Haploid progeny from dipa single protein sequence can adopt multiple conformations is loids were isolated by micromanipulation and verified by phenoa biological phenomenon that is still relatively unclear. Just as typic assays and mating type testing.
Hsp104 mutants from the original mutagenized strains
gene expression is regulated by an intricate network of transcription factors and promoter elements, prion variant propagation is were amplified by PCR and cloned into the pRS306 integratregulated by a network of chaperones and in some cases, other ing vector. The mutants were integrated into a clean 74-D694
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Figure 6. hsp104-G730D can propagate multi-dot high [RNQ+]. hsp104G730D cells were mated to s.d. low (low), medium (med), high (high), very
high (v.high) and m.d. high (m.d. high) [RNQ+] and then sporulated. The
hsp104-G730D haploid progeny from four separate tetrads of each variant mating, along with the unmated [RNQ+] variants as controls (WT),
were analyzed by SDD-AGE and western blot.

background by the pop-in/pop-out method and verified by
DNA sequencing. The pProEx-Htb-Hsp104 purification plasmid has previously been described.29 Hsp104 mutations were
cloned into pProEx-Htb-Hsp104 by restriction digest with
BamHI and Bsu36I followed by ligation and sequencing to verify the mutation.
The “strong” and “weak” [PSI+] variants were characterized
and kindly provided by the Chernoff and Liebman labs.17 The
Sc37 [PSI+] variant was made by transforming Sup35NM fibers
generated at 37 °C into [psi−] cells. These strains were made
and kindly provided by the Weissman lab.49 The [RNQ+] variant strains were characterized as specific [PIN+] strains initially,
but later confirmed to be [RNQ+], and were kindly provided by
the Liebman lab.59,60 To analyze the Hsp104 mutants in both
[RNQ+] and [PSI+] variants, each variant was mated to both
hsp104-G254D [psi−][rnq−] and hsp104-G730D [psi−][rnq−]
cells and diploids were selected. The diploids were sporulated and
dissected by micromanipulation.
EMS mutagenesis screen
A strong [PSI+] yeast strain was subjected to EMS mutagenesis
as previously described.34 Two cultures with viabilities of about
17% were plated to determine changes in color. Candidates were
selected based on color phenotype and were initially identified
as mutations in HSP104 by backcrossing to an hsp104Δ strain
and analyzing the progeny for segregation of the phenotype.
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Genomic DNA was PCR amplified and sequenced to identify
the point mutations in HSP104.
SDD-AGE
SDD-AGE analysis was performed as previously described.
Cells were lysed by beadbeating in PEB buffer (25 mM Tris-HCl
pH 7.5, 50 mM KCl, 10 mM MgCl2, 1 mM EDTA, 10% Glycerol
plus mini EDTA-free protease inhibitors [Roche], Aprotinen
[Sigma] and PMSF [Sigma]). Samples were incubated in sample
buffer at room temperature for seven minutes then separated on a
1.5% agarose gel. The protein distribution was analyzed by western blot with anti-Sup35 antibodies or anti-Rnq1 antibodies.
Hsp104 purification
Recombinant Hsp104 was expressed in E. coli cells and
purified as previously described with one further separation
step added.23 Briefly, Hsp104, tagged with a 6xHis tag on the
N-terminus, was first isolated on a Nickel-sepharose column, the
6 ´ His tag was cleaved off using the TEV protease, and Hsp104
was re-applied to the Nickel-sepharose column to separate the
untagged Hsp104. Untagged Hsp104 was then applied to an
anion exchange Q-sepharose column followed by an S-300 size
exclusion column to isolate monomeric Hsp104 from any aggregated Hsp104 species. Untagged, monomeric Hsp104 was stored
at −80 °C in a storage buffer (20 mM Tris pH 8.0, 100 mM
NaCl, 10 mM MgCl2, 2 mM EDTA, 10% glycerol).
ATP hydrolysis assays
ATP hydrolysis was measured by the Malachite green assay
as previously described.64 Briefly, 2 µg of purified protein was
incubated in buffer (40 mM TrisHCl pH7.5, 175 mM NaCl,
5 mM MgCl2, 0.02% Triton X-100) with 5 mM ATP at 37 °C.
At various times, Malachite green dye was added to the sample
for one minute and the reaction was stopped by the addition of
34% citric acid. The dye absorbance was determined at 650 nm
and the amount of free phosphate calculated based on a standard
of KH2PO4.
Glycerol gradients
Purified Hsp104 was applied to a 4 mL linear (10–35%) glycerol gradient and centrifuged at 34k rpm for 18 h in a SLA-600
rotor. Gradients were fractionated and equal volumes of each
fraction were analyzed by SDS-PAGE and western blot using
an anti-Hsp104 antibody. Individual bands from each fraction
were quantified using Image J and reported as a percent of total
Hsp104.
Thermotolerance
An equal number of cells from cultures of HSP104, hsp104G254D, hsp104-G730D, and hsp104Δ grown to mid-log phase
were pre-treated at 37 °C to induce HSP104 expression then heatshocked at 50 °C. At the indicated time intervals, samples were
taken and spotted on rich media in a 5-fold serial dilution.
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